跳至主要内容
临床试验/JPRN-UMIN000031107
JPRN-UMIN000031107招募中未知

Efficacy and safety study of intratympanic dexamethasone treatment concurrent with standard oral prednisolone treatment for facial palsy - Intratympanic dexamethasone therapy for facial palsy

agoya City University, Graduate school of Medical sciences0 个研究点目标入组 53 人开始时间: 2018年2月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
53

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Presence of non-viral inflammation in the idle ear. The presence of the carriage state of viral or bacterial disease. Middle ear or inner ear anomaly which makes it impossible to inject to the middle ear. HbA1C > 6.5% BUN >25 mg/dl or Serum creatinine level>2.0 mg/dl ALT > 100 U/l or AST > 100/l Severe protracted wound healing. Signs of central facial palsy Pregnancy, or possible pregnancy Participate in other clinical traials within 3 months Recurrent facial palsy Treatment other than 60 mg of prednisolone and 1000 mg (Bell's palsy) or 3000 mg (Hunt syndrome)of oral valaciclovir within two days straight History of facial nerve decompression surgery The patients who are considered not to be appropriate for the clinical trial

研究者

发起方
agoya City University, Graduate school of Medical sciences

相似试验